<i>cd9b</i> MO caused a decrease in neuromasts deposited at 52 hpf. by Katherine S. Marsay (11772718)

“…B-G: Representative images of WISH of <i>claudin b</i> at 52 hpf of (b) uninjected embryos, (c) embryos with 0.5 μM Mismatch, (d) 0.1 μM <i>cd9b</i> MO1, (e) 0.1 μM <i>cd9b</i> i2e3 MO1, (f) 0.2 μM <i>cd9b</i> MO1, (g) 0.2 μM <i>cd9b</i> i2e3 MO. …”

Phenethyl isothiocyanate activates leptin signaling and decreases food intake by Miho Yagi (5921252)

“…Leptin is a weight-reducing hormone produced by adipose tissue, which decreases food intake <i>via</i> hypothalamic leptin receptors (Ob-Rb) and the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway. …”

Ba₂NaClP₂O₇: Unprecedented Phase Matchability Induced by Symmetry Breaking and Its Unique Fresnoite-Type Structure by Jie Chen (5892)

“…The uniaxial symmetry breaking caused by the disorder of [P₂O₇]^4– group results in a structural anisotropy that changes the band dispersions along <i>k</i>-paths of G–Y and G–X, resulting in an increase of refractive index <i>n</i>_<i>x</i> and a <i>n</i>_<i>y</i> decrease, eventually enlarging the birefringence.…”

Combination metabolic therapy decreases VM-M3 cell viability <i>in vitro</i>. by A. M. Poff (752552)

“…<b>(A-B)</b> βHB, LG, and LG+βHB+HBOT treatment decreased viability compared to control and HBOT treated cells. …”

Patient characteristics and treatment history (N = 33, all TNBCs^†). by Ting-Fang He (5210948)

Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…Cell density was measured with trypan blue hemocytometry to produce a growth curve over 96 hours. <b>(A)</b> Proliferation of VM-M3 cells was inhibited with decreasing glucose concentration and the addition of HBOT. …”

Decreased proliferation in tuft endothelium despite increased VEGFA level in N-CAM deficient retinas in OIR. by Joakim Håkansson (200855)

“…(A, B) Decrease in endothelial cell proliferation in N-CAM deficient retinas (B) compared to wt (A) was restricted to the tufts, whereas the remaining vasculature was unaffected (arrowheads indicate veins). …”

Data_Sheet_1_Coenzyme A-Dependent Tricarboxylic Acid Cycle Enzymes Are Decreased in Alzheimer’s Disease Consistent With Cerebral Pantothenate Deficiency.PDF by Crystal Sang (12856397)

S5 Data - by Ayuta Kishimoto (16814662)

Subjects:

Data_Sheet_1_The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries.docx by Cui Zhou (1388874)

S100A12 decreased SAA-induced ERK1/2 and MEK1/2 phosphorylation. by Yuen Ming Chung (406571)

One-way sensitivity analysis, <i>Immediate ART</i> strategy compared to <i>ART<350/μL</i>. by Eric N. Ouattara (6890174)

Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

“…H&E staining shows 5-week-old <i>Slc39a13</i>-KO skin is thinner than wild-type littermates (left), without significant difference in epidermis (right; enlarged view of blue-boxed area 1). …”

Complex IV deficiency led to decreased levels of SIRT1, SIRT3 and SIRT4 as well as decreased NAD⁺ concentrations. by Arne Björn Potthast (4529689)

CDK16 protein level is decreased in <i>Ccnyl1</i>-/- testis. by Zhenzhen Zi (787008)

LDLR level is decreased in extrahepatic tissues of <i>AnxA2</i>^−/− mice. by Nabil G. Seidah (148050)

SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

“…<p>(A) Microarray gene expression analysis of postmortem dorsolateral PFC (DLPFC) samples collected from patients with PTSD shows decreased levels of SGK1 mRNA. …”

<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. by Siyun Lee (17087351)

“…Mock vs ECE treatment (N = 4), *: <i>p</i> < 0.05, **: <i>p</i> < 0.01, ***: <i>p</i> < 0.005. …”

No significant sex differences in Iso-induced decrease of CaD₈₀. by Gregory S. Hoeker (650231)

“…B) Summary data for the decrease in CaD₈₀ (versus baseline values) as a function of the dose of Iso (1, 10, 31.6, 100, 316.2 nM) in the LV base <i>(left)</i> and apex <i>(right)</i> with pacing at 3 (<i>top</i>) and 5.5 Hz (<i>bottom</i>) for female (n = 5) and male (n = 5) hearts. …”

Number of SB-SNPRs (<i>s</i> = 5) of which at least one of the authors is also one of the inventors of the citing patent (N(ai)) as a function of the publication year of the SB-SNP... by Anthony F. J. van Raan (7517696)